Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
20.32
-0.28 (-1.36%)
At close: Mar 28, 2025, 4:00 PM
20.49
+0.17 (0.82%)
After-hours: Mar 28, 2025, 7:56 PM EDT

Summit Therapeutics Market Cap

Summit Therapeutics has a market cap or net worth of $14.99 billion as of March 28, 2025. Its market cap has increased by 373.65% in one year.

Market Cap
14.99B
Enterprise Value
14.58B
1-Year Change
373.65%
Ranking
Category
Stock Price
$20.32

Market Cap Chart

Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $14.99B, an increase of 12,496.35%. That is a compound annual growth rate of 61.64%.

History

DateMarket Cap% Change
Mar 28, 202514.99B13.91%
Dec 31, 202413.16B619.43%
Dec 29, 20231.83B113.79%
Dec 30, 2022855.60M225.45%
Dec 31, 2021262.90M-32.00%
Dec 31, 2020386.60M653.61%
Dec 31, 201951.30M203.55%
Dec 31, 201816.90M-87.66%
Dec 29, 2017137.00M30.60%
Dec 30, 2016104.90M-21.83%
Dec 31, 2015134.20M12.77%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings